PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
about
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.Central Modulation of Neuroinflammation by Neuropeptides and Energy-Sensing Hormones during Obesity.Secoisolariciresinol diglucoside is a blood-brain barrier protective and anti-inflammatory agent: implications for neuroinflammation.Vitamin C supplementation in the critically ill: A systematic review and meta-analysis
P2860
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
PARP inhibition in leukocytes ...... otects the blood-brain barrier
@nl
PARP inhibition in leukocytes ...... tects the blood-brain barrier.
@ast
PARP inhibition in leukocytes ...... tects the blood-brain barrier.
@en
type
label
PARP inhibition in leukocytes ...... otects the blood-brain barrier
@nl
PARP inhibition in leukocytes ...... tects the blood-brain barrier.
@ast
PARP inhibition in leukocytes ...... tects the blood-brain barrier.
@en
prefLabel
PARP inhibition in leukocytes ...... otects the blood-brain barrier
@nl
PARP inhibition in leukocytes ...... tects the blood-brain barrier.
@ast
PARP inhibition in leukocytes ...... tects the blood-brain barrier.
@en
P2093
P2860
P921
P3181
P1476
PARP inhibition in leukocytes ...... tects the blood-brain barrier.
@en
P2093
Holly Dykstra
Nancy L Reichenbach
Sachin Gajghate
Viviana Zuluaga-Ramirez
Yuri Persidsky
P2860
P2888
P3181
P356
10.1186/S12974-016-0729-X
P50
P577
2016-09-27T00:00:00Z
P6179
1033755133